Member Sector:  Association

The Nanomedicines Innovation Network (NMIN) is advancing “smart” medicines to defeat disease by delivering small molecule drugs to disease sites and accelerating gene therapy.

NMIN brings 60 Principal Investigators from 17 institutions across Canada together with 15 companies and 8 not-for-profit research and granting institutions to establish a network to expand and improve Canada’s position as a leader in nanomedicines R&D.

NMIN is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.